197 related articles for article (PubMed ID: 2122877)
21. Expression of secreted phosphoprotein 1 (osteopontin) in human sensorimotor cortex and spinal cord: Changes in patients with amyotrophic lateral sclerosis.
Yamamoto T; Murayama S; Takao M; Isa T; Higo N
Brain Res; 2017 Jan; 1655():168-175. PubMed ID: 27823929
[TBL] [Abstract][Full Text] [Related]
22. The role of immune processes in amyotrophic lateral sclerosis pathogenesis.
Alexianu ME
Rom J Neurol Psychiatry; 1995; 33(3-4):215-27. PubMed ID: 8729177
[TBL] [Abstract][Full Text] [Related]
23. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis.
Alexianu ME; Ho BK; Mohamed AH; La Bella V; Smith RG; Appel SH
Ann Neurol; 1994 Dec; 36(6):846-58. PubMed ID: 7998770
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of monoclonal immunoglobulins in serum of patients with amyotrophic lateral sclerosis.
Duarte F; Binet S; Lacomblez L; Bouche P; Preud'homme JL; Meininger V
J Neurol Sci; 1991 Jul; 104(1):88-91. PubMed ID: 1919600
[TBL] [Abstract][Full Text] [Related]
25. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Kawamata T; Akiyama H; Yamada T; McGeer PL
Am J Pathol; 1992 Mar; 140(3):691-707. PubMed ID: 1347673
[TBL] [Abstract][Full Text] [Related]
26. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS).
Niebroj-Dobosz I; Dziewulska D; Janik P
Folia Neuropathol; 2006; 44(3):191-6. PubMed ID: 17039414
[TBL] [Abstract][Full Text] [Related]
27. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis.
Engelhardt JI; Tajti J; Appel SH
Arch Neurol; 1993 Jan; 50(1):30-6. PubMed ID: 8093428
[TBL] [Abstract][Full Text] [Related]
28. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.
Sta M; Sylva-Steenland RM; Casula M; de Jong JM; Troost D; Aronica E; Baas F
Neurobiol Dis; 2011 Jun; 42(3):211-20. PubMed ID: 21220013
[TBL] [Abstract][Full Text] [Related]
29. Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival.
Chiot A; Zaïdi S; Iltis C; Ribon M; Berriat F; Schiaffino L; Jolly A; de la Grange P; Mallat M; Bohl D; Millecamps S; Seilhean D; Lobsiger CS; Boillée S
Nat Neurosci; 2020 Nov; 23(11):1339-1351. PubMed ID: 33077946
[TBL] [Abstract][Full Text] [Related]
30. [Two autopsy cases of sporadic amyotrophic lateral sclerosis with 20-year-clinical course without respirators].
Kato S; Oda M; Hayashi H; Komori T; Hirose K; Tanabe H; Arai N
No To Shinkei; 1993 Mar; 45(3):267-72. PubMed ID: 8323821
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients.
Lim GP; Backstrom JR; Cullen MJ; Miller CA; Atkinson RD; Tökés ZA
J Neurochem; 1996 Jul; 67(1):251-9. PubMed ID: 8666998
[TBL] [Abstract][Full Text] [Related]
32. Evidence for an early innate immune response in the motor cortex of ALS.
Jara JH; Genç B; Stanford MJ; Pytel P; Roos RP; Weintraub S; Mesulam MM; Bigio EH; Miller RJ; Özdinler PH
J Neuroinflammation; 2017 Jun; 14(1):129. PubMed ID: 28651542
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons.
Engelhardt JI; Siklós L; Kömüves L; Smith RG; Appel SH
Synapse; 1995 Jul; 20(3):185-99. PubMed ID: 7570350
[TBL] [Abstract][Full Text] [Related]
34. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients.
Shibata N; Nagai R; Uchida K; Horiuchi S; Yamada S; Hirano A; Kawaguchi M; Yamamoto T; Sasaki S; Kobayashi M
Brain Res; 2001 Oct; 917(1):97-104. PubMed ID: 11602233
[TBL] [Abstract][Full Text] [Related]
35. Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS).
Niebrój-Dobosz I; Dziewulska D; Kwieciński H
Folia Neuropathol; 2004; 42(3):151-6. PubMed ID: 15535033
[TBL] [Abstract][Full Text] [Related]
36. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM
Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553
[TBL] [Abstract][Full Text] [Related]
37. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis.
Troost D; Van den Oord JJ; Vianney de Jong JM
Neuropathol Appl Neurobiol; 1990 Oct; 16(5):401-10. PubMed ID: 2263315
[TBL] [Abstract][Full Text] [Related]
39. Autoradiography with [3H]PK11195 of spinal tract degeneration in amyotrophic lateral sclerosis.
Sitte HH; Wanschitz J; Budka H; Berger ML
Acta Neuropathol; 2001 Feb; 101(2):75-8. PubMed ID: 11271375
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients.
Munoz DG; Greene C; Perl DP; Selkoe DJ
J Neuropathol Exp Neurol; 1988 Jan; 47(1):9-18. PubMed ID: 3334727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
